Innate Immune Cytosolic DNA Sensors as Novel Protumorigenic Drivers in Stomach Cancer
Abstract
The majority of gastric cancer (GC) cases is associated with chronic inflammation resulting from uncontrolled activation of the body's two arms of the immune system, innate and adaptive immunity. However, current immune-based treatments for GC patients have only focused on a select few adaptive immune checkpoint inhibitors with limited clinical benefits, whereas the clinical utility of innate immunity remains underexplored in GC.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jul 01, 2023
- Accession Number
- AD1212450
Entities
People
- Brendan J. Jenkins
- Ruby Dawson
Organizations
- Monash University